First-Episode Psychosis: Early Signs, Assessment, Treatment, and Recovery
Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
First-episode psychosis (FEP) means a person's first recognized period of clinically significant psychotic symptoms. It is an important reason for prompt medical and psychiatric assessment because treatment can reduce distress, improve functioning, identify medical or substance-related causes, and connect the person with specialized early-intervention care. An initial episode can be frightening or confusing for the individual and people around them, but the episode itself does not establish schizophrenia or determine how the person's future will unfold.
Psychosis describes a clinical syndrome involving altered perception, beliefs, thinking, or behavior, commonly including hallucinations, delusions, or disorganization. It can occur in schizophrenia-spectrum disorders, mood disorders, medical and neurological conditions, and during substance or medication effects. Understanding this distinction is fundamental to assessing a first episode. The National Institute of Mental Health's explanation of psychosis and the 2023 VA/DoD clinical practice guideline both emphasize early recognition, assessment, and individualized treatment.
For someone experiencing possible psychosis now, the practical priority is timely professional evaluation. New psychotic symptoms accompanied by severe confusion, fever, seizures, profound agitation, an inability to meet basic needs, or immediate danger call for emergency medical care. A person should also receive urgent help if voices direct self-harm or if there are suicidal thoughts, intentions, or plans. In the United States, call 911 for an immediate emergency; 988 offers crisis support. These pathways are complementary to specialized first-episode services.
I. What Is First-Episode Psychosis?
First-episode psychosis is a description of a clinical presentation and stage of care, not a single disease with a unique biological test. Clinicians usually use the term when clinically significant psychotic symptoms have recently appeared or are being treated for the first time. The phrase first episode does not always mean symptoms began on the day care started. Some people experience weeks or months of symptoms before anyone recognizes their clinical significance.
A person may hear a voice that others cannot hear, develop a fixed belief that other people are monitoring them, become convinced ordinary coincidences carry secret messages, or have speech so difficult to follow that communication and everyday activities are disrupted. Experiences differ in intensity, duration, distress, conviction, and relationship to cultural beliefs. Clinicians evaluate these experiences in context rather than treating any unusual thought as proof of psychosis.
Psychosis may arise during a mood episode; follow substance use, intoxication, withdrawal, or exposure to certain medications; accompany a neurological or systemic illness; or develop within a primary psychotic disorder. At the first assessment, the most accurate formulation may be 'first presentation of psychosis, cause under investigation.' Longitudinal follow-up may clarify the diagnosis. The VA/DoD guideline for first-episode psychosis explicitly treats suspected psychosis, evaluation, and condition-specific treatment as connected but distinct clinical decisions.
Does first-episode psychosis mean schizophrenia?
No. Schizophrenia is one possible diagnosis, requiring characteristic symptoms, functional and duration criteria, and exclusion of alternative explanations under the relevant diagnostic system. Other possible diagnoses include brief psychotic disorder, schizophreniform disorder, schizoaffective disorder, a mood disorder with psychotic features, substance-induced psychotic disorder, and psychosis due to another medical condition. The first episode is a starting point for diagnosis and care, not a shortcut to a lifelong label. See the NIMH schizophrenia overview for the disorder's clinical features and the importance of early treatment.
II. Early Signs: What May Appear Before and During an Episode
The changes preceding a first episode vary. Some people experience relatively abrupt symptoms; others describe gradually increasing difficulties with sleep, concentration, social interaction, work, school, or interpreting everyday events. A deterioration in functioning may deserve assessment even when the reason remains unclear. Early changes are nonspecific and can also occur with anxiety, depression, trauma, insomnia, substance exposure, neurological disease, or ordinary periods of high stress.
Possible warning changes include withdrawing from friends, missing school or work, losing interest in usual activities, becoming intensely suspicious, seeming unusually preoccupied with private meanings, having increasing difficulty organizing thoughts, or experiencing a major change in self-care. Family members may notice a pronounced change from the person's previous level of functioning. The presence of one or several of these changes cannot predict a psychotic disorder. The NIMH Understanding Psychosis guidance describes warning signs and recommends obtaining an evaluation when they appear.
Hallucinations and unusual perceptual experiences
A hallucination is a perception-like experience without an external stimulus corresponding to it. Hearing voices is one example; visual, tactile, olfactory, and other experiences are also possible. A person may experience a voice as external, internal, familiar, threatening, or neutral. Clinicians ask whether the experience occurs while awake, while falling asleep or waking, in the context of substances, or alongside confusion or neurological symptoms. Hallucinations also occur outside schizophrenia, so the phenomenology and medical context matter.
Delusions, suspiciousness, and altered interpretation
A delusion is a belief held with unusually strong conviction despite substantial counterevidence and outside what is ordinarily accepted within the individual's cultural or religious context. During a first episode, someone might believe that messages on television are directed specifically at them or that they are being pursued without adequate evidence. Suspiciousness by itself is not a diagnosis: the clinician examines how firmly the belief is held, its effects on functioning, the evidence considered, and whether realistic threats or traumatic experiences could explain the concern.
Disorganized thinking, behavior, and changes in function
Thinking may become difficult to track in conversation, with abrupt topic shifts or responses that do not answer the question. Behavior may be increasingly unpredictable, slowed, or disorganized. Negative symptoms, including diminished motivation, reduced expressive behavior, or social withdrawal, may also affect daily life; these need careful distinction from depression, adverse medication effects, fatigue, and environmental deprivation. Cognition, sleep, work, education, relationships, and daily functioning all belong in a comprehensive assessment, not only hallucinations and delusions.
Clinical high risk is different from established psychosis
A specialist may identify a clinical high-risk state for psychosis (CHR-P) when attenuated or intermittent symptoms and other defined criteria are present. CHR-P is established using structured clinical assessment in an appropriate population; it is neither an online screening score nor a confirmed psychotic disorder. An updated meta-analysis of specialist high-risk cohorts estimated transition to psychosis in approximately one quarter over three years, but this is a group-level observation shaped by referral patterns and study differences. Most people in these cohorts had not developed psychosis by three years. The estimate cannot be used to predict an individual person's outcome. See the JAMA Psychiatry meta-analysis of CHR-P transition.
For people at increased risk who do not meet diagnostic criteria for psychosis, NICE CG178 recommends specialist assessment, psychological support where appropriate, and ongoing monitoring. It specifically advises against prescribing antipsychotic medication solely to prevent a first episode. This recommendation for at-risk states is distinct from medication decisions after established first-episode psychosis.
III. When to Seek Help, and When Assessment Is Urgent
A new, persistent hallucination, firmly held implausible belief, markedly disorganized speech, or striking deterioration in everyday functioning warrants prompt clinical evaluation. An early psychosis team, psychiatrist, primary care clinician, urgent mental-health service, or emergency department can help determine the appropriate level of care. The goal is to connect the person with help quickly while avoiding unnecessary confrontation and stigma.
Seek immediate emergency medical assessment when symptoms occur with sudden or fluctuating confusion, fever, severe headache, seizure, new weakness, head trauma, significant intoxication or withdrawal, or other signs of acute physical illness. Likewise, catatonic signs such as severe immobility or inability to eat or drink can indicate a medical emergency. Assessors must also address potential self-harm, suicidal behavior, inability to care for basic needs, and immediate threats to safety. These warning signs may indicate causes that need urgent medical treatment, irrespective of whether a primary psychotic disorder is eventually diagnosed. The VA/DoD evaluation pathway includes assessment of suspected psychosis and medical alternatives.
If symptoms are not immediately dangerous, an urgent appointment remains appropriate. 'Wait until it becomes severe' is an especially poor strategy when social withdrawal or confusing experiences are already disrupting life. NICE states that people presenting with first-episode psychosis should be assessed without delay by early-intervention services, with urgent crisis referral where those services cannot meet immediate needs.
IV. How Clinicians Assess a First Episode
The assessment begins with a respectful conversation about the person's actual experiences, how symptoms have changed, and the effect on daily life. When appropriate and with the person's involvement and consent, clinicians may obtain collateral history from family or someone who knows the person well. This can help establish a timeline, especially where insight, memory, or disorganization complicates self-report. A relationship of trust improves the chance that the individual will disclose distressing or embarrassing experiences.
The clinician assesses hallucinations, beliefs, thought form, behavior, mood, sleep, cognition, orientation, attention, and functioning. They also ask about depression, mania, anxiety, traumatic experiences, suicidal thoughts, prior episodes, family history, medication exposures, substance use, and developmental history. Substance use matters because intoxication, withdrawal, and persistent substance-associated psychotic states can resemble primary psychosis. The inquiry should be matter-of-fact rather than accusatory.
A physical examination and targeted investigations help look for medical causes or complications. Depending on presentation, medical evaluation may include vital signs, neurological examination, metabolic and hematologic tests, toxicology when indicated, assessment for infection, or other tests selected for a specific clinical concern. Brain imaging, EEG, lumbar puncture, or autoimmune investigations are considered when signs and history suggest a corresponding neurological or medical condition; a universal list of tests is inappropriate for every patient. The VA/DoD 2023 guideline outlines evaluation and management of suspected psychosis, while NICE CG178 specifies multidisciplinary assessment of physical health and medication risks.
What questions are asked during the assessment?
Useful questions concern when symptoms first appeared, what the person experiences, whether the experiences interfere with sleeping or working, whether the person feels safe, whether there have been mood episodes, and what changed around the onset. Clinicians also ask which explanations the person finds meaningful, which supports are available, and which goals matter most. The answer to 'What do you want help with first?' may reveal immediate priorities such as sleep, fear, school attendance, housing, or restoring contact with friends.
Is there a test that confirms first-episode psychosis?
There is no single blood test, brain scan, personality inventory, or online checklist that establishes first-episode psychosis or determines whether someone has schizophrenia. Structured symptom scales can support assessment and track treatment response, but diagnosis rests on clinical history, observed findings, the course of symptoms, and consideration of alternatives. An abnormal screening score should lead to further evaluation, never direct self-diagnosis.
V. Differential Diagnosis: Why a First Episode Needs a Broad View
In a primary psychotic disorder, hallucinations, delusions, or disorganization can be central features of the illness, but the final label depends on the duration and pattern of symptoms, functional change, mood episodes, and diagnostic exclusions. The duration thresholds and boundaries of schizophrenia-spectrum conditions are classification-dependent. An initial diagnosis may appropriately remain provisional while the clinician observes the course.
Psychosis in bipolar disorder may occur during severe mood episodes, particularly mania or depression, while major depressive disorder can also involve psychotic features. Distinguishing these presentations requires careful examination of the relationship between psychotic symptoms and mood episodes over time. The treatment approach can differ considerably. NICE specifically directs clinicians to mood-disorder guidance when the first presentation suggests affective psychosis.
Delirium often involves an acute and fluctuating disturbance of attention and awareness, commonly associated with illness, medications, or toxic-metabolic problems. New hallucinations alongside disorientation or changing alertness need a medical rather than a purely psychiatric explanation. Neurological conditions, seizures, autoimmune or infectious illness, endocrine or metabolic abnormalities, and medication effects can also produce psychotic symptoms. These possibilities are evaluated according to the clinical presentation.
Strong anxiety, obsessive intrusive thoughts, trauma-related experiences, dissociation, and sleep-related hallucinations may sometimes be confused with psychosis. The nature of the experience, degree of conviction, insight, accompanying symptoms, and functional course guide the differential diagnosis. For an English-language comparison already published by the Hub, see Neurosis vs Psychosis: Meaning, Reality Testing, Symptoms, and Modern Diagnosis. Its historical vocabulary does not replace modern clinical assessment.
VI. Early Treatment: Why the First Response Matters
Early intervention combines fast access with a treatment plan that addresses symptoms, health, relationships, learning, work, and individual goals. Prompt care is recommended, but claims that every day of delay causes irreversible brain damage go beyond what the research establishes. A 2024 systematic review and meta-analysis found meaningful benefits of early-intervention strategies across quality of life and several functional and clinical outcomes, while evidence that early-detection programs consistently shorten the duration of untreated psychosis was more limited.
Duration of untreated psychosis (DUP) usually refers to the time between the onset of psychotic symptoms and adequate treatment, although researchers operationalize this interval differently. Longer untreated intervals are often associated with poorer outcomes, but association alone does not demonstrate that the delay itself caused the difference: illness severity, access to services, social conditions, and other variables may also contribute. A recent systematic review of short versus long DUP underscores outcome associations and variability in study definitions. This evidence supports prompt access without blaming patients or families for a delayed recognition.
Coordinated specialty care in the United States
Coordinated specialty care (CSC) is a team-based early psychosis model that integrates individualized medication management, psychotherapy, family education and support, case management, and supported employment or education. Peer support and physical health services may also be available. The person participates in planning and goal-setting. The intention is to make care continuous and relevant to everyday life rather than splitting treatment into unrelated appointments.
The NIMH-funded RAISE Early Treatment Program evaluated NAVIGATE, a coordinated intervention for people with first-episode psychosis. In a cluster-randomized comparison with usual community services, NAVIGATE participants experienced better quality of life and greater participation in work or school over two years, with patterns influenced by duration of untreated psychosis. These are study-level findings, not a guaranteed individual response. See the RAISE randomized study in the American Journal of Psychiatry and the NIMH explanation of coordinated specialty care.
In the U.S., people can search for early psychosis and recent-onset serious mental illness programs through the SAMHSA Early Serious Mental Illness Treatment Locator. Programs differ in age criteria, geography, referral requirements, and services. A local clinician or insurer can also help identify an available team.
VII. Antipsychotic Medication in a First Episode
When an established psychotic episode requires antipsychotic treatment, the choice is made with a qualified prescribing clinician and tailored to symptom severity, previous responses, coexisting conditions, preferences, and safety. Antipsychotics can reduce hallucinations, delusions, and agitation in many patients, although the magnitude and time course of response vary. An individualized plan also considers whether the presentation is primarily psychotic, mood-related, substance-related, or medically caused.
The NICE guideline recommends oral antipsychotic medication combined with psychological interventions for first-episode psychosis. This recommendation is not an instruction to self-medicate. NICE advises that initiation in primary care for a first presentation of sustained psychosis should occur only in consultation with a consultant psychiatrist. If an informed person prefers to begin with psychological interventions alone, the guideline recommends careful monitoring and a short agreed review interval of a month or less to revisit medication options.
Medication selection should explicitly discuss metabolic changes such as weight gain and abnormal glucose or lipids; movement-related symptoms, including akathisia and dystonia; sedation; cardiovascular effects; prolactin-related effects; and the individual's priorities. Baseline and follow-up monitoring may include body weight, blood pressure, glucose or HbA1c, lipids, movement symptoms, and other assessments relevant to the chosen medication. NICE's first-episode prescribing and monitoring recommendations provide a detailed clinical framework. Medication dose adjustments, discontinuation, or switching should be discussed with the prescriber because relapse risk and withdrawal-related effects require individualized planning.
A first episode alone does not establish treatment resistance and does not automatically call for clozapine. Clozapine is reserved for specific treatment-resistant schizophrenia indications and requires specialized laboratory and medical monitoring. Long-acting injectable medications may be discussed when appropriate, including based on patient preference and adherence needs, but the choice is individualized. The VA/DoD 2023 first-episode and schizophrenia guideline addresses these treatment decisions within a monitored clinical framework.
VIII. Psychological, Family, and Practical Interventions
Cognitive behavioral therapy for psychosis (CBTp) aims to reduce distress, improve coping, examine interpretations of experiences, strengthen functioning, and support personal goals. It does not require a therapist to invalidate the person's experience. A clinician can explore how certainty, fear, sleep disruption, stress, and social withdrawal interact while remaining respectful and curious. Its use alongside medication is part of established specialist guidance. NICE CG178 explains delivery of CBT and family intervention for psychosis.
Family psychoeducation helps relatives understand psychotic symptoms, the treatment pathway, communication challenges, warning signs, and how to provide support without blame. Depending on consent and circumstances, relatives may participate in joint planning or receive their own education and support. Services should respect confidentiality and the person's preferences while explaining legitimate safety-related information sharing.
Supported education and employment are active components of recovery. A student may need help returning to classes, obtaining accommodations, or managing coursework. A worker may need a paced return, job support, or workplace adjustments. Housing stability, financial resources, social connectedness, sleep, substance-use support, and physical health care can materially affect recovery. Cognitive remediation may be considered for relevant cognitive difficulties within a broader individualized rehabilitation plan; it is distinct from acute treatment of hallucinations or delusions.
IX. What Recovery Can Look Like
Recovery is multidimensional. Symptom improvement matters, but the goals may also include finishing school, returning to a job, maintaining friendships, living independently, improving physical health, feeling safe, and participating in decisions. Some people experience remission after an initial episode; others need longer support or encounter recurrent symptoms. A diagnosis made early in the course may change after additional history becomes available. Neither the first presentation nor the most severe moment predicts one unavoidable life trajectory.
Follow-up involves tracking symptoms, function, medication benefits and adverse effects, sleep, substance exposure, physical health, and the person's own sense of well-being. Teams may collaboratively identify individual warning signs of recurrence and agree on whom to contact if difficulties intensify. Discontinuing prescribed medication or withdrawing from follow-up without planning can create avoidable risks. NICE's recovery recommendations favor continuing access to comprehensive community treatment and carefully monitored changes.
Relapse prevention is a shared project rather than a demand for constant surveillance. A plan may include earlier appointments if sleep or unusual experiences change, strategies for reducing stress, practical support for work or study, and clear emergency contacts. It should be revised as the individual develops preferences and learns what helps.
X. How to Support Someone Who May Be Experiencing Psychosis
Begin with calm, clear, respectful communication. Ask about distress and safety, listen without ridicule, and avoid escalating an argument about whether a belief is true. It is possible to acknowledge that an experience feels frightening while expressing a different understanding of events. Offer help arranging an assessment, transportation, a supportive companion, and a quiet environment when appropriate.
If the person fears services, ask what specifically worries them: hospitalization, medication effects, finances, privacy, discrimination, or losing autonomy. Practical discussion about these concerns may make a clinical conversation easier. Offer choices wherever the immediate safety situation permits. Do not secretly administer medication or make promises about treatment outcomes. An early psychosis program can often discuss referral options with families even when the person is uncertain about attending.
Carers need support too. The NICE adult psychosis guideline recommends providing accessible information to carers and offering education and support early. Supporting someone can involve real emotional, financial, and logistical strain. Maintaining healthy boundaries, adequate rest, and a crisis plan benefits everyone involved.
XI. Special Considerations in Young People
First-episode psychosis often first draws clinical attention in adolescence or early adulthood, but psychosis can appear outside this age range. Adolescents require age-appropriate assessment that considers development, safeguarding, family context, schooling, and the full range of possible medical and psychiatric explanations. Symptoms in a child or teen should not automatically be interpreted using adult pathways.
NICE CG155 recommends specialist assessment of children and young people with a first presentation of sustained psychotic symptoms and describes condition-specific medication and psychological interventions. Parents and caregivers can help provide developmental history, but the young person's voice, confidentiality rights, and participation in care remain central.
XII. Common Misunderstandings About the First Episode
A first episode is not a synonym for schizophrenia. The diagnostic process can remain open while clinicians address symptoms and safety. Hallucinations are not unique to schizophrenia, and unusual beliefs need contextual assessment. Psychological distress, online self-tests, or a person's claim that they 'feel psychotic' cannot substitute for evaluation.
There is no evidence-based basis for assuming that every person with psychosis is violent, incapable of decision-making, or destined for lifelong disability. Stigma and barriers to services can delay care, jeopardize relationships, and discourage disclosure. Person-centered language and recovery-oriented services encourage engagement. The NIMH overview emphasizes treatability and the importance of timely support.
Early treatment matters, but it is neither a promise of immediate symptom disappearance nor proof that an earlier episode could always have been prevented. Effective services combine clinical treatment with persistent, adaptable support. For some people, building trust with providers is a necessary first stage of care.
XIII. Frequently Asked Questions
How long does a first episode of psychosis last?
There is no universal duration. Symptoms may last days, weeks, months, or longer depending on their cause, severity, and treatment, and diagnostic labels depend partly on duration and course. Urgent assessment is justified by concerning symptoms and functional change rather than waiting for a specific calendar threshold to pass.
Can someone experience psychosis once and never again?
Yes, some people have a single episode followed by sustained recovery, while others experience recurrence or persistent symptoms. Outcome depends on multiple factors, and clinicians cannot determine an individual's long-term course from a single early presentation. Ongoing follow-up helps clarify diagnosis and adapt care.
Can lack of sleep or cannabis cause psychotic symptoms?
Severe sleep disruption may contribute to perceptual or cognitive disturbances, and cannabis or other substances can precipitate or aggravate psychotic symptoms in some people. These associations do not establish a cause in an individual, and apparent substance-related psychosis still requires assessment for medical and psychiatric alternatives. New or severe symptoms warrant professional evaluation.
What if someone does not believe they need treatment?
Start by asking about what feels distressing or difficult to them, then offer an appointment framed around sleep, stress, safety, or functioning if appropriate. Avoid coercive arguments about a label. For emergencies or inability to care for essential needs, urgent professional evaluation may be necessary under local legal and clinical procedures. A specialist service can advise families on supportive approaches.
Is hospitalization always necessary?
No. Some people can be assessed and treated safely through urgent outpatient or community early-intervention services with reliable support and follow-up. Hospital admission may be needed when acute medical evaluation, severe symptoms, dangerous behavior, marked inability to care for oneself, or inadequate community safety makes it necessary. The decision is individualized.
Does everyone need the same antipsychotic treatment?
No. Medication decisions depend on the cause of psychosis, expected benefit, adverse-effect risks, age, medical history, and preference. Prescribing and monitoring are clinician-led. Some presentations require different treatments because psychotic symptoms arise from mood disorders, medications, or physical illnesses.
What is the best first step for someone seeking care in the United States?
If there is immediate danger or a possible medical emergency, use emergency services. Otherwise contact a qualified health professional or local early psychosis program promptly; the SAMHSA Early Serious Mental Illness Treatment Locator lists programs for recent-onset conditions. Bring a symptom timeline, medication and substance history, and questions about safety, privacy, treatment preferences, school, or work.
XIV. A Practical Pathway From Concern to Ongoing Care
For a person or family dealing with a possible first episode, the workable sequence is recognition of a meaningful change, prompt safety and medical assessment, specialist diagnostic formulation, an individualized care plan, and follow-up that addresses daily functioning. Establishing contact with a coordinated specialty care team can make these stages easier to navigate. Some people begin in an emergency department; others come through primary care, school, family referrals, or direct contact with a community program.
Ask the service whether it offers first-episode psychosis assessment, what age group it accepts, how urgent referrals are managed, and which clinical, psychological, educational, and family supports are available. Ask how the team handles medication monitoring, changes in diagnosis, confidentiality, crisis planning, and transitions after early-intervention services. These questions help people judge whether the program fits their needs.
A respectful assessment opens the possibility of treatment without treating a frightening experience as an identity. Early access, careful differential diagnosis, shared decision-making, and support for valued life goals form the practical foundation of first-episode psychosis care.
Related Articles
Neurosis vs Psychosis: Meaning, Reality Testing, Symptoms, and Modern Diagnosis — an existing English-language comparison of historical terminology and modern clinical assessment.
Neuroticism and Psychosis: Trait Associations and Diagnostic Boundaries — clarification of personality-trait associations and their limits for diagnosis.
References
American Psychiatric Association. (2020). The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. Official guideline directory.
Catalan, A., et al. (2025). “Short” versus “long” duration of untreated psychosis in people with first-episode psychosis: A systematic review and meta-analysis of baseline status and follow-up outcomes. Schizophrenia Bulletin, 51(5), 1206–1230. https://doi.org/10.1093/schbul/sbae201
Kane, J. M., et al. (2016). Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE Early Treatment Program. American Journal of Psychiatry, 173(4), 362–372. https://doi.org/10.1176/appi.ajp.2015.15050632.
National Institute for Health and Care Excellence. (2013). Psychosis and schizophrenia in children and young people: Recognition and management (CG155). Official recommendations.
National Institute for Health and Care Excellence. (2014; recommendations subsequently amended). Psychosis and schizophrenia in adults: Prevention and management (CG178). Official recommendations.
National Institute of Mental Health. (n.d.). Schizophrenia. Official NIMH publication.
National Institute of Mental Health. (n.d.). Understanding psychosis. Official NIMH publication.
Salazar de Pablo, G., et al. (2021). Probability of transition to psychosis in individuals at clinical high risk: An updated meta-analysis. JAMA Psychiatry, 78(9), 970–978. https://doi.org/10.1001/jamapsychiatry.2021.0830
Salazar de Pablo, G., et al. (2024). Duration of untreated psychosis and outcomes in first-episode psychosis: Systematic review and meta-analysis of early detection and intervention strategies. Schizophrenia Bulletin, 50(4), 771–783. https://doi.org/10.1093/schbul/sbae017.
Substance Abuse and Mental Health Services Administration. (2026). Early Serious Mental Illness Treatment Locator. Official U.S. treatment locator.
U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). Management of First-Episode Psychosis and Schizophrenia: VA/DoD Clinical Practice Guideline. Official 2023 guideline and resources.